R

Rhythm Pharmaceuticals

Commercializes MC4R-targeted therapies for rare obesity

Associate Director - Biostatistics

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeBoston, MA, USA

About the Job

Requirements

  • A PhD in Statistics, Biostatistics, or a related quantitative discipline, with approximately 5+ years of relevant clinical trial experience in biopharma, biotech, or CRO settings; or an MS in Statistics, Biostatistics, or a related discipline with approximately 8+ years of relevant experience.
  • Strong understanding of statistical concepts and clinical trial methodologies, with the ability to apply them to practical development and analysis challenges.
  • Knowledge of the drug development process and experience supporting clinical studies across one or more phases of development.
  • Proficiency with SAS and R.
  • Familiarity with CDISC requirements, including SDTM and ADaM standards.
  • Ability to manage multiple priorities, projects, and timelines while maintaining attention to quality and detail.
  • Communication, presentation, and report-writing skills sufficient to explain complex statistical concepts clearly to cross-functional and non-statistical audiences.
  • Ability to work independently within established strategic direction, collaborate across functions, and adapt to evolving priorities in a fast-paced biotech environment.
  • Willingness and ability to work in the Boston office in coordination with the department and business needs.

Responsibilities

  • Serve as the statistical lead for assigned clinical studies or defined program activities, contributing to clinical development plans, study design, sample size and power calculations, protocols, statistical analysis plans, tables, listings, and figures, data analyses, and interpretation of results.
  • Collaborate with cross-functional partners to support study strategy, execution, and decision-making, ensuring statistical considerations are incorporated into clinical plans and deliverables.
  • Prepare and review statistical content for protocols, clinical study reports, integrated summaries of safety and efficacy, and other submission-related or study-level documents.
  • Oversee statistical vendors for assigned deliverables, including review, validation, and quality control of outputs to ensure accuracy, consistency, and compliance with company standards.
  • Work closely with statistical programmers to review key efficacy and safety outputs, support dry runs and quality control, identify data or analysis issues, and help drive timely resolution.
  • Support interim analyses, Data and Safety Monitoring Board meetings, ad hoc analyses, and other statistical activities required to advance clinical program needs.
  • Contribute to statistical components of global regulatory submissions, including relevant sections of CTD Modules 2.5, 2.7, and 5, as needed.
  • Support the presentation of statistical analyses and results in INDs, NDAs, BLAs, MAAs, J-NDAs, and other regulatory submissions or briefing materials.
  • Partner with data management on case report forms, data management plans, edit checks, data review activities, and related processes that support high-quality analysis outputs.
  • Contribute to departmental standards, templates, process improvements, and practical solutions that enhance quality, efficiency, and inspection readiness.

Desired Qualifications

  • Experience with sample size software such as EAST.
  • Experience contributing to IND, NDA, BLA, MAA, J-NDA, or other regulatory submission deliverables.

About the Company

Rhythm Pharmaceuticals

Commercializes MC4R-targeted therapies for rare obesity

Rhythm Pharmaceuticals focuses on developing therapies for rare neuroendocrine genetic obesity disorders, led by IMCIVREE (setmelanotide). IMCIVREE is an MC4R agonist that restores signaling in the MC4R pathway to curb hunger and regulate energy use; it is FDA, EC, and MHRA approved for Bardet-Biedl syndrome and certain POMC/PCSK1/LEPR deficiencies in patients aged 2 and older, with revenue from global sales. The company differentiates itself by pursuing precision medicine for MC4R pathway diseases and advancing additional MC4R programs like bivamelagon and RM-718. Rhythm’s goal is to broaden access to MC4R-targeted therapies for rare patient populations and grow its pipeline toward sustainable commercialization.

Company size
501-1,000
Company stage
IPO
Headquarters
Boston, MA
Founded
2008

Recently Posted Jobs

Explore more opportunities at Rhythm Pharmaceuticals

See more jobs